- Home
- TUSK vs ALEC Comparison
TUSK vs ALEC Comparison
Compare TUSK & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TUSK
- ALEC
- Stock Information
- Founded
- TUSK 2014
- ALEC 2013
- Country
- TUSK United States
- ALEC United States
- Employees
- TUSK N/A
- ALEC N/A
- Industry
- TUSK Oilfield Services/Equipment
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TUSK Energy
- ALEC Health Care
- Exchange
- TUSK Nasdaq
- ALEC Nasdaq
- Market Cap
- TUSK 109.4M
- ALEC 124.0M
- IPO Year
- TUSK 2016
- ALEC 2019
- Fundamental
- Price
- TUSK $2.05
- ALEC $1.32
- Analyst Decision
- TUSK
- ALEC Hold
- Analyst Count
- TUSK 0
- ALEC 9
- Target Price
- TUSK N/A
- ALEC $3.40
- AVG Volume (30 Days)
- TUSK 92.4K
- ALEC 5.2M
- Earning Date
- TUSK 10-31-2025
- ALEC 11-06-2025
- Dividend Yield
- TUSK N/A
- ALEC N/A
- EPS Growth
- TUSK N/A
- ALEC N/A
- EPS
- TUSK N/A
- ALEC N/A
- Revenue
- TUSK $186,316,000.00
- ALEC $81,130,000.00
- Revenue This Year
- TUSK N/A
- ALEC N/A
- Revenue Next Year
- TUSK $28.22
- ALEC $290.64
- P/E Ratio
- TUSK N/A
- ALEC N/A
- Revenue Growth
- TUSK 84.11
- ALEC 46.77
- 52 Week Low
- TUSK $1.68
- ALEC $0.87
- 52 Week High
- TUSK $4.00
- ALEC $6.14
- Technical
- Relative Strength Index (RSI)
- TUSK 37.52
- ALEC 25.34
- Support Level
- TUSK $2.01
- ALEC $1.45
- Resistance Level
- TUSK $2.15
- ALEC $1.68
- Average True Range (ATR)
- TUSK 0.09
- ALEC 0.19
- MACD
- TUSK -0.01
- ALEC -0.11
- Stochastic Oscillator
- TUSK 14.29
- ALEC 1.42
About TUSK Mammoth Energy Services Inc.
Mammoth Energy Services Inc is an integrated energy services company engaged in providing products and services to enable the exploration and development of North American onshore unconventional oil and natural gas reserves as well as the construction and repair of the electric grid for private utilities, public investor-owned utilities, and co-operative utilities through infrastructure services businesses. The company had three reportable segments, which includes well completion services (Well Completion), infrastructure services (Infrastructure) and natural sand proppant services (Sand). Key revenue is generated from Infrastructure which include electric utility infrastructure services to government-funded utilities, private utilities, public investor-owned utilities, etc.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.